(Press-News.org) Roland Martin, MD, a world-class neurologist and investigator, is the winner of the 2023 John Dystel Prize for MS Research. He is being honored for advancing our understanding of immune mechanisms underlying multiple sclerosis and translating them to develop innovative strategies to treat the disease.
Martin uncovered how key MS susceptibility genes are involved in launching immune attacks on the nervous system and identified specific components of nerve-insulating myelin that are targeted by those attacks. His team has developed an experimental therapy designed to make the immune system ignore those targets but leave the rest of the protective immune system intact. This strategy is now in clinical testing.
Martin is Professor Emeritus at the University of Zurich’s Institute for Experimental Immunology. He also holds positions as Senior Scientist at the Karolinska Institutet in Stockholm and Chief Scientific Officer at the biotech company Cellerys® AG.
“Professor Martin has made major contributions to our understanding of the underlying immune activity at work in MS,” said Dr. Bruce Bebo, Executive Vice President of Research at the National Multiple Sclerosis Society. “His team has brought us closer than ever to finding a way to turn off only the destructive immune activities in MS, while retaining the body’s ability to ward off infections.”
Previous Dystel Prize winner Stephen L. Hauser, M.D., nominated Martin for the prize. “Roland Martin is a remarkably creative physician-scientist and neurologist whose brilliant investigations have profoundly advanced knowledge of the fundamental biology of MS,” he commented. “His discoveries – bridging genetics, epidemiology, and immunology – revealed how inheritance, coupled with critical environmental exposures, can lead to a misdirected immune attack against the nervous system. He has given us a new understanding of how MS might begin.”
Martin’s work has revealed how immune B cells play a role in activating immune T cells to enter the brain and spinal cord and target specific tissue components in MS and has offered clues to how infectious agents or gut bacteria could trigger MS immune attacks. He has also provided care for people with MS throughout his career, has conducted early clinical trials testing novel therapies in MS, and was responsible for making aHSCT available in Switzerland for people with active MS.
In addition to recent leadership positions, Martin served as director of clinical MS research at the University of Hamburg, held staff positions at the National Institutes of Health, and has served as advisor to many organizations in the U.S. and Europe. He received his medical degree from the University of Würtzburg and additional training at the National Institutes of Health, the University of Tübingen, and the University of Maryland. He has authored over 425 papers and book chapters.
Martin will deliver the Dystel Prize lecture and receive the award at the American Academy of Neurology 2023 Annual Meeting, in Boston, MA, on April 24.
# # #
About the John Dystel Prize for MS Research
The Dystel Prize is awarded jointly by the National MS Society and the American Academy of Neurology. It was established in 1994 by former Society National Board member the late Oscar Dystel, and his wife the late Marion Dystel, in honor of their son, John Jay Dystel, an attorney whose promising career was cut short by progressive disability from MS, and complications of the disease that lead to his death in June 2003. about other Dystel Prize winners.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.
About the National Multiple Sclerosis Society
The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, Twitter, Instagram, YouTube or 1-800-344-4867.
END
Colorectal cancer (CRC) is the fourth most common cancer and accounts for 11% of the cancer burden in Thailand in 2020, with over 21,000 new CRC cases annually, and stage III and IV CRC account for up to 70%–80% of overall CRC cases, according to the Society of Colorectal Surgeons of Thailand.
This report indicates Thailand has a high percentage of respondents (62.1%) who feel they lack CRC information to assess their risk, far higher than global average of 51.5%. In addition, 48.2% of Thais say that cost concerns are holding them back from CRC screening, way higher than global average of ...
First study to do apples-to-apples comparison of residential treatment use among Medicaid enrollees across several states
Nine states represent 14.9 million people (20% of all Medicaid enrollees)
CHICAGO --- Approximately 7 million adults in the U.S. are living with opioid use disorder (OUD). Yet a new Northwestern Medicine study that measured residential treatment use among Medicaid enrollees across nine states found only 7% of enrollees with OUD received residential treatment, an integral part of the recovery process ...
Researchers from NC State University and Texas A&M University published a new Journal of Marketing article that examines membership fee shipping programs and the effect on consumers’ purchase behaviors and company net revenue.
The study, forthcoming in the Journal of Marketing, is titled “The Effectiveness of Membership-Based Free Shipping: An Empirical Investigation of Consumers’ Purchase Behaviors and Revenue Contribution” and is authored by Fangfei Guo and Yan Liu.
What is the top reason 50% of customers abandon items in online shopping carts? Why do e-commerce brands incur an annual revenue loss of about ...
Whether wriggling your toes or lifting groceries, muscles in your body smoothly expand and contract. Some polymers can do the same thing — acting like artificial muscles — but only when stimulated by dangerously high voltages. Now, researchers in ACS Applied Materials & Interfaces report a series of thin, elastic films that respond to substantially lower electrical charges. The materials represent a step toward artificial muscles that could someday operate safely in medical devices.
Artificial muscles could become key components of movable soft robotic implants and functional artificial organs. Electroactive elastomers, such as bottlebrush polymers, are attractive ...
Developing and testing new treatments or vaccines for humans almost always requires animal trials, but these experiments can sometimes take years to complete and can raise ethical concerns about the animals’ treatment. Now, researchers reporting in ACS Central Science have developed a new testing platform that encapsulates B cells — some of the most important components of the immune system — into miniature “organoids” to make vaccine screening quicker and greatly reduce the number of animals needed.
Vaccines ...
Single-use hard plastics are all around us: utensils, party decorations and food containers, to name a few examples. These items pile up in landfills, and many biodegradable versions stick around for months, requiring industrial composting systems to fully degrade. Now, researchers reporting in ACS Sustainable Chemistry & Engineering have created a sturdy, lightweight material that disintegrates on-demand — and they made it from sugar and wood-derived powders. Watch a video about the material here.
Sturdy, degradable materials made from plants and other non-petroleum sources have come ...
Early diagnosis and treatment of Alzheimer’s disease requires reliable and cost-effective screening methods. Researchers at Karolinska Institutet in Sweden have now discovered that a type of sugar molecule in blood is associated with the level of tau, a protein that plays a critical role in the development of severe dementia. The study, which is published in Alzheimer's & Dementia, can pave the way for a simple screening procedure able to predict onset ten years in advance.
“The role of glycans, ...
The ancestors of modern mammals managed to evolve into one of the most successful animal lineages – the key was to start out small and simple, a new study reveals.
In many vertebrate groups, such as fishes and reptiles, the skull and lower jaw of animals with a backbone are composed of numerous bones. This was also the case in the earliest ancestors of modern mammals over 300 million years ago.
However, during evolution the number of skull bones was successively reduced in early mammals around 150 to 100 million years ago.
Publishing their findings today ...
In 1918, the American chemist Irving Langmuir published a paper examining the behavior of gas molecules sticking to a solid surface. Guided by the results of careful experiments, as well as his theory that solids offer discrete sites for the gas molecules to fill, he worked out a series of equations that describe how much gas will stick, given the pressure.
Now, about a hundred years later, an “AI scientist” developed by researchers at IBM Research, Samsung AI, and the University of Maryland, Baltimore County (UMBC) has reproduced a key part of Langmuir’s Nobel Prize-winning work. The system—artificial intelligence ...
Researchers of the Genome Dynamics Project team at Tokyo Metropolitan Institute of Medical Science ·revealed new mechanism controlling cellular proliferation in response to serum, which triggers growth of resting cells.
One of the key pathways for cellular growth is the phosphoinositide 3-kinase (PI3K) –mTOR (mechanistic/mammalian target of rapamycin) pathway. mTOR regulates the cellular response to nutrient availability. Dysregulation of the mTOR signaling pathway is intimately involved in many human diseases, especially the multitude of different human cancers. This ...
